← FDA DRUG APPROVALS

FDA ANDA · ANDA202440

CLINDAMYCIN AND BENZOYL PEROXIDE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA202440
TYPE
ANDA
ORIGINAL APPROVAL
2015-09-21
LATEST ACTION
2015-09-21
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDEPrescription
BENZOYL PEROXIDE 5%, CLINDAMYCIN PHOSPHATE EQ 1% BASE · GEL · TOPICAL

Approval history

2015-09-21UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →